GWM
BMRN icon

Gupta Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Gupta Wealth Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$18K Hold
220
– – ﹤0.01% 673
2015
Q4 		$23K Hold
220
– – 0.01% 622
2015
Q3 		$23K Hold
220
– – 0.01% 658
2015
Q2 		$30K Hold
220
– – 0.01% 629
2015
Q1 		$27K Buy
+220
New +$23.3K 0.01% 517

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Gupta Wealth Management's BMRN Position: Q1 2016 in Review

Gupta Wealth Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q1 2016 at 220 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Gupta Wealth Management first reported a position in BMRN in Q1 2015 and has held it in 5 quarters since. The position peaked at $30K in Q2 2015. 391 funds tracked by Wall St. Rank hold BMRN as of Q1 2016.

  • Gupta Wealth Management held 220 shares of BioMarin Pharmaceuticals worth $18K as of Q1 2016.
  • Gupta Wealth Management left its BioMarin Pharmaceuticals share count unchanged in Q1 2016.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #673 holding.
  • Gupta Wealth Management first reported a position in BioMarin Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's BioMarin Pharmaceuticals position peaked at $30K in Q2 2015.
  • 391 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.